| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/12/2011 | US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 |
| 04/12/2011 | US7923532 Oligopeptide for use in prevention and treatment of gluten allergies |
| 04/12/2011 | US7923431 Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| 04/12/2011 | US7923250 Transfection with nucleic acid; insertion |
| 04/12/2011 | US7923247 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| 04/12/2011 | US7923243 Expression vector comprising glucose regulated protein 78 (grp78) stress-responsive promoter and endoplasmic reticulum stress elements for use in tissue specific heterologous gene expression for treatment and prevention of cell proliferative and inflammatory disorders |
| 04/12/2011 | US7923236 Fungal enzymes |
| 04/12/2011 | US7923235 CIP1 polypeptides and their uses |
| 04/12/2011 | US7923225 Method for the enzymatic production of 2-hydroxy-2-methyl carboxylic acids |
| 04/12/2011 | US7923221 Methods of making antibody heavy and light chains having specificity for a desired antigen |
| 04/12/2011 | US7923216 In vivo modulation of neuronal transport |
| 04/12/2011 | US7923212 Antibodies to cytokine receptor zalpha11 |
| 04/12/2011 | US7923209 Allergen peptide fragments and use thereof |
| 04/12/2011 | US7923208 Using presence of variation in Zcytor16 gene sequences as evaluative tool in diagnosis of cell proliferative disorders |
| 04/12/2011 | US7923017 Modified Vaccinia Ankara virus variant |
| 04/12/2011 | US7923016 Engineered CXCL12 α locked dimer polypeptide |
| 04/12/2011 | US7923015 Methods for direct visualization of active synapses |
| 04/12/2011 | US7923012 Immunizing an animal using polypeptide; amino acid sequences; controlling phosphate, vitamin D metabolism |
| 04/12/2011 | US7923008 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab |
| 04/12/2011 | CA2488775C Fcyriia transgenic animal model for autoimmune disease |
| 04/12/2011 | CA2456172C Kidney-specific urate transporter and uses thereof |
| 04/12/2011 | CA2438427C Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
| 04/12/2011 | CA2434060C Preparation of a therapeutic composition |
| 04/12/2011 | CA2400908C Fusion protein having enhanced in vivo erythropoietin activity |
| 04/12/2011 | CA2361725C Selection of proteins using rna-protein fusions |
| 04/12/2011 | CA2326719C Use of triplex structure dna sequences for transferring nucleotide sequences |
| 04/12/2011 | CA2050318C Endothelial cell growth factor, methods of isolation and expression |
| 04/12/2011 | CA1341611C Interleukin-1 receptors |
| 04/07/2011 | WO2011041790A1 Piscine reovirus diagnostic compositions |
| 04/07/2011 | WO2011041789A1 Piscine reovirus immunogenic compositions |
| 04/07/2011 | WO2011041504A1 Polypeptides derived from thermoascus crustaceus having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/07/2011 | WO2011041405A1 Polypeptides having xylanase activity and polynucleotides encoding same |
| 04/07/2011 | WO2011041397A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/07/2011 | WO2011041376A1 Modified granulocyte colony stimulating factor (g-csf) |
| 04/07/2011 | WO2011041233A1 Improved lov-d acyltransferase mediated acylation |
| 04/07/2011 | WO2011041231A1 Variant lovd polypeptides and their uses |
| 04/07/2011 | WO2011041093A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| 04/07/2011 | WO2011040978A2 Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof |
| 04/07/2011 | WO2011040887A1 A nuclear receptor and mutant thereof and the use of the same in the reprogramming of cells |
| 04/07/2011 | WO2011040823A1 Synthetic myostatin peptide antagonists |
| 04/07/2011 | WO2011040654A1 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same |
| 04/07/2011 | WO2011040535A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | WO2011040421A1 Screening method |
| 04/07/2011 | WO2011040417A1 Inositol-1,4,5-trisphosphate receptor binding protein, and transgenic non-human mammal containing same |
| 04/07/2011 | WO2011039729A1 Use of sirna targetting sipa1l1 for the reduction of adipogenesis |
| 04/07/2011 | WO2011039639A2 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7 |
| 04/07/2011 | WO2011039584A2 Peptides |
| 04/07/2011 | WO2011039508A2 T-cell receptor |
| 04/07/2011 | WO2011039507A1 T-cell receptor capable of recognising an antigen from cytomegalovirus |
| 04/07/2011 | WO2011039382A1 Antibacterial polypeptides and use thereof |
| 04/07/2011 | WO2011039350A1 New markers for the diagnosis of celiac disease |
| 04/07/2011 | WO2011039345A1 Spider mite silk proteins |
| 04/07/2011 | WO2011039096A1 Drug fusions and conjugates with extended half life |
| 04/07/2011 | WO2011038900A2 Peptide analogues of glucagon for diabetes therapy |
| 04/07/2011 | WO2011038689A1 Novel human cytokine vstm1-v2 and use thereof |
| 04/07/2011 | WO2011014680A3 Gastric inhibitory peptide variants and their uses |
| 04/07/2011 | WO2011008746A3 Serum markers associated with early and other stages of breast cancer |
| 04/07/2011 | WO2011003935A4 Parathyroid hormone related protein antagonists |
| 04/07/2011 | WO2011002077A8 TNF-α GENE THERAPY AGENT CONTAINED IN POLYMERIC MICELLE |
| 04/07/2011 | WO2010151159A3 Virus-like particle vector as a polyvalent platform for intracellular delivery of high-molecular-weight therapeutic substances, method for generating a virus like particle vector and use of a virus-like particle vector and a pharmaceutical composition containing said virus-like particle vector |
| 04/07/2011 | WO2010135491A3 Fibroblast growth factor mutants having improved functional half-life and methods of their use |
| 04/07/2011 | WO2010132758A3 Ospc-based diagnostic test for lyme disease |
| 04/07/2011 | WO2010132609A3 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 04/07/2011 | WO2010125079A3 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 04/07/2011 | WO2010121352A8 Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy |
| 04/07/2011 | WO2010119343A3 Compositions for immunising against staphylococcus aerus |
| 04/07/2011 | WO2010097788A9 Visfatin therapeutic agents for the treatment of acne and other conditions |
| 04/07/2011 | US20110083230 Gene cluster involved in biosynthesis of isopentenyl diphosphate in the non-mevalonate pathway of hevea brasiliensis |
| 04/07/2011 | US20110083229 EG1117 And EG307 Polynucleotides And Uses Thereof |
| 04/07/2011 | US20110083224 Quantitative Trait Loci Associated With Soybean Cyst Nematode Resistance and Uses Thereof |
| 04/07/2011 | US20110082287 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110082285 Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins |
| 04/07/2011 | US20110082283 Multimeric elp fusion constructs |
| 04/07/2011 | US20110082282 Process of preparing conjugates of allium organosulfur compounds with amino acids, peptides, and proteins |
| 04/07/2011 | US20110082279 Chemiluminescent Compounds |
| 04/07/2011 | US20110082277 Modified bio-related substance, process for producing the same, and intermediate |
| 04/07/2011 | US20110082095 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 04/07/2011 | US20110082094 Mammalian Cytokine-Like Polypeptide-10 |
| 04/07/2011 | US20110082093 Methods and compositions for treating trinucleotide repeat disorders |
| 04/07/2011 | US20110082089 Biomarkers for monitoring or predicting the treatment of cancer |
| 04/07/2011 | US20110082082 Skin wound healing compositions and methods of use thereof |
| 04/07/2011 | US20110082079 Glucagon-like peptide-1 derivatives and their pharmaceutical use |
| 04/07/2011 | US20110082078 Methods and compositions for treating neuropathies |
| 04/07/2011 | US20110082077 Sialic acid derivatives for protein derivatisation and conjugation |
| 04/07/2011 | US20110082074 Agent for preventing periodontal disease |
| 04/07/2011 | US20110082073 Modified Cpn10 and PRR signalling |
| 04/07/2011 | US20110082052 Phage displaying system expressing single chain antibody |
| 04/07/2011 | US20110081730 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic target |
| 04/07/2011 | US20110081705 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 04/07/2011 | US20110081683 Methods of combined bioprocessing and related microorganisms, thermophilic and/or acidophilic enzymes, and nucleic acids encoding said enzymes |
| 04/07/2011 | US20110081663 Molecular Probe for Imaging of Pancreatic Islets and Use of the Same |
| 04/07/2011 | US20110081662 Screening methods for bone morphogenetic mimetics |
| 04/07/2011 | US20110081661 Modified photoproteins with increased affinity for calcium and enhanced bioluminescence and uses thereof |
| 04/07/2011 | US20110081660 Method for Detecting Misfolded Proteins and Prions |
| 04/07/2011 | US20110081659 Substrates for glycogen synthase kinase 3 enzymes and methods of use |
| 04/07/2011 | US20110081658 T1r3 binding assays |
| 04/07/2011 | US20110081656 Secreted proteins and uses thereof |
| 04/07/2011 | US20110081381 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110081369 Immune modulation with death receptor-induced apoptosis |
| 04/07/2011 | US20110081366 Immunostimulatory nucleic acid molecules |